XML 34 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Business and Principal Activities (Details Narrative)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Apr. 11, 2024
USD ($)
Investor
$ / shares
shares
Jan. 26, 2024
USD ($)
Investor
$ / shares
shares
Apr. 03, 2023
USD ($)
shares
Nov. 10, 2022
USD ($)
$ / shares
Sep. 30, 2024
USD ($)
$ / shares
Jun. 30, 2024
USD ($)
shares
Mar. 31, 2024
USD ($)
shares
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
shares
Mar. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Proceeds from sale of equity                     $ 59,200    
Net proceeds from offerings         $ 53,800           53,800    
Cash and cash equivalents         $ 9,563           $ 9,563   $ 1,173
Common stock, par value | $ / shares         $ 0.0001           $ 0.0001   $ 0.0001
Net loss         $ 2,471 $ 2,389 $ 1,076 $ 1,421 $ 2,327 $ 3,257 $ 5,936 $ 7,005  
Accumulated deficit         47,341           47,341   $ 41,405
Maximum possible proceeds from offerings       $ 50,000             9,700    
Threshold per share limit for exercise of warrants | $ / shares       $ 10.80                  
Gross proceeds from registered direct offering     $ 5,000                    
Net proceeds from registered direct offering     4,300                    
Placement agent fees     400                    
Other professional expenses     $ 300                    
Gross proceeds from private placement                     $ 15,016 $ 5,000  
Common Stock [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Net loss              
Number of common stock issued | shares           6,960,864 6,133,414   1,000,000        
Prefunded Common Stock Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Sale of common stock | shares     1,557,632                    
April 2023 Common Warrant [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares     1,947,040                    
Private Placement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares 701,243                        
Number of accredited investors | Investor 172 92                      
Gross proceeds from private placement $ 11,100 $ 6,100                      
Other professional expenses $ 200 $ 700                      
Number of common stock issued | shares   6,133,414                      
Warrants rights term 5 years 5 years                      
Warrants exercise price | $ / shares $ 1.69 $ 0.99                      
Net proceeds from offering $ 9,600                        
Placement agent fees $ 1,300                        
Private Placement [Member] | Common Stock [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Number of common stock issued | shares 6,960,864                        
Private Placement [Member] | Prefunded Common Stock Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares 951,500                        
Warrants exercise price | $ / shares $ 0.0001                        
Private Placement [Member] | Series A Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares 7,912,364                        
Warrants rights term 5 years                        
Warrants exercise price | $ / shares $ 1.22                        
Private Placement [Member] | Series B Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares 3,956,182                        
Warrants rights term 2 years                        
Warrants exercise price | $ / shares $ 1.22                        
Private Placement [Member] | Director [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   1.22                      
Private Placement [Member] | Officer [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   1.22                      
Private Placement [Member] | Employees [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   1.22                      
Private Placement [Member] | Consultants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants exercise price | $ / shares   $ 1.22                      
Private Placement [Member] | Placement Agent Agreement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants rights term   5 years                      
January 2024 Common Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares   6,133,414                      
January 2024 PA Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants to purchase common stock | shares   511,940